Literature DB >> 11735162

Thrombolytic therapy: 2001.

V J Marder1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11735162     DOI: 10.1054/blre.2001.0161

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


× No keyword cloud information.
  6 in total

1.  Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.

Authors:  Sergei Zaitsev; Kristina Danielyan; Juan-Carlos Murciano; Kumkum Ganguly; Tatiana Krasik; Ronald P Taylor; Steven Pincus; Steven Jones; Douglas B Cines; Vladimir R Muzykantov
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

2.  Locally Deliver the Tissue-Type Plasminogen Activator (tPA) Plasmid for Preventing Thrombosis.

Authors:  Kuo-Chen Wei
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

Review 3.  Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.

Authors:  Harry Messmore; Walter Jeske; William Wehrmacher; Jeanine Walenga
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis.

Authors:  Hung-Wei Yang; Mu-Yi Hua; Kun-Ju Lin; Shiaw-Pyng Wey; Rung-Ywan Tsai; Siao-Yun Wu; Yi-Ching Lu; Hao-Li Liu; Tony Wu; Yunn-Hwa Ma
Journal:  Int J Nanomedicine       Date:  2012-10-01

5.  Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.

Authors:  Yu Huang; Boram Gu; Isabelle I Salles-Crawley; Kirk A Taylor; Li Yu; Jie Ren; Xuhan Liu; Michael Emerson; Colin Longstaff; Alun D Hughes; Simon A Thom; Xiao Yun Xu; Rongjun Chen
Journal:  Sci Adv       Date:  2021-06-02       Impact factor: 14.136

6.  Multiphysics Modelling and Simulation of Thrombolysis via Activated Platelet-Targeted Nanomedicine.

Authors:  Boram Gu; Yu Huang; Emily Louise Manchester; Alun D Hughes; Simon A McG Thom; Rongjun Chen; Xiao Yun Xu
Journal:  Pharm Res       Date:  2022-01-19       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.